Mainz Biomed N.V.
MYNZ
$4.37
-$0.365-7.72%
| 12/31/2023 | 12/31/2022 | 09/30/2022 | |||
|---|---|---|---|---|---|
| Revenue | 11.12% | 141.63% | 81.25% | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 11.12% | 141.63% | 81.25% | ||
| Cost of Revenue | -49.04% | -6.27% | -31.70% | ||
| Gross Profit | 271.07% | 141.49% | 135.09% | ||
| SG&A Expenses | -7.49% | 13.47% | 24.44% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | -20.71% | 78.24% | 47.66% | ||
| Operating Income | 21.44% | -77.17% | -47.10% | ||
| Income Before Tax | 36.70% | -43.30% | -20.62% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | 36.70% | -43.30% | -20.62% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | 36.70% | -43.30% | -20.62% | ||
| EBIT | 21.44% | -77.17% | -47.10% | ||
| EBITDA | 24.47% | -78.46% | -45.70% | ||
| EPS Basic | 49.70% | 16.71% | 26.64% | ||
| Normalized Basic EPS | 42.81% | -1.17% | 10.91% | ||
| EPS Diluted | 49.70% | 16.71% | 26.64% | ||
| Normalized Diluted EPS | 42.81% | -1.17% | 10.91% | ||
| Average Basic Shares Outstanding | 25.87% | 72.04% | 64.42% | ||
| Average Diluted Shares Outstanding | 25.87% | 72.04% | 64.42% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||
